-
Product Insights
NewPhosphodiesterase 9 – Drugs In Development, 2024
The Phosphodiesterase 9 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Hematological Disorders, and Undisclosed which include indications of Congestive Heart Failure (Heart Failure), Systolic Heart Failure, Alzheimer's Disease, Parkinson's Disease, Sickle Cell Disease, Thalassemia, and Unspecified Rare Disease. It also...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Empagliflozin in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Empagliflozin in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Empagliflozin in Chronic Kidney Disease (Chronic Renal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Empagliflozin in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Empagliflozin in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Empagliflozin in Pulmonary Arterial Hypertension Drug Details: Empagliflozin (Jardiance, BI...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Balcinrenone in Congestive Heart Failure (Heart Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Balcinrenone in Congestive Heart Failure (Heart Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Balcinrenone in Congestive Heart Failure (Heart Failure) Drug...
-
Product Insights
NewSarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 – Drugs In Development, 2024
The Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 pipeline drugs market research report outlays comprehensive information on the Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Oncology, Central Nervous System, and Metabolic Disorders which include indications of Congestive Heart Failure (Heart Failure), Acute Heart Failure, Triple-Negative Breast Cancer (TNBC), Solid Tumor, Parkinson's Disease,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Balcinrenone in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Balcinrenone in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Balcinrenone in Chronic Kidney Disease (Chronic Renal...
-
Product Insights
NewAdenosine Receptor A1 – Drugs In Development, 2024
The Adenosine Receptor A1 pipeline drugs market research report outlays comprehensive information on the Adenosine Receptor A1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Oncology, and Respiratory which include indications of Parkinson's Disease, Alzheimer's Disease, Cardiac Arrest, Congestive Heart Failure (Heart Failure), Solid Tumor, Unspecified Cancer, Asthma, and Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – It-hMSC in Congestive Heart Failure (Heart Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - It-hMSC in Congestive Heart Failure (Heart Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. It-hMSC in Congestive Heart Failure (Heart Failure) Drug...
-
Product Insights
NewCaM Kinase – Drugs In Development, 2024
The CaM Kinase pipeline drugs market research report outlays comprehensive information on the CaM Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Oncology, and Respiratory which include indications of Arrhythmias, Congestive Heart Failure (Heart Failure), Alzheimer's Disease, Parkinson's Disease, Prostate Cancer, Triple-Negative Breast Cancer (TNBC), and Asthma. It also reviews key players...